Gene therapy for hemophilia is revolutionizing the way this genetic bleeding disorder is managed, offering hope to thousands affected by the condition.Hemophilia B, a rare illness stemming from a deficiency in clotting factor IX, has traditionally required patients to undergo regular injections of clotting factors to mitigate bleeding risks.